SetPoint Medical is a privately held biomedical technology company dedicated to treating patients with debilitating inflammatory diseases using proprietary implantable neuromodulation devices. SetPoint™s approach is intended to offer patients and providers an alternative approach for the treatment of RA and other chronic inflammatory diseases with less risk and cost than drug therapy.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/08/13 | $27,000,000 |
Action Potential Venture Capital Boston Scientific Flare Capital Partners GlaxoSmithKline Morgenthaler Topspin Fund | undisclosed | |
| 09/08/15 | $15,000,000 | Series C-1 |
Action Potential Venture Capital Boston Scientific Foundation Medical Partners Morgenthaler | undisclosed |
| 08/28/17 | $300,000,000 | Series D |
Action Potential Venture Capital Boston Scientific Medtronic Morgenthaler Topspin Partners | undisclosed |
